Antiretroviral therapy duration and immunometabolic state determine efficacy of ex vivo dendritic cell-based treatment restoring functional HIV-specific CD8+ T cells in people living with HIV is a research paper published in EBioMedicine (2022). On theSindex it has a DataRank of 0.505. It has been cited 28 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.505
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 5R21AI140930-02
Tailored induction of HIV-1 specific immunity through engineered dendritic cell vaccines
FWCI
1.67
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 7 of Identification of CD8+ T cell subsets that normalize in early-treated people living with HIV receiving antiretroviral therapy
Additional file 7 of Identification of CD8+ T cell subsets that normalize in early-treated people living with HIV receiving antiretroviral therapy
Additional file 8 of Identification of CD8+ T cell subsets that normalize in early-treated people living with HIV receiving antiretroviral therapy
Additional file 8 of Identification of CD8+ T cell subsets that normalize in early-treated people living with HIV receiving antiretroviral therapy